Appointment of Chief Quality Officer
Paiania, June 11, 2026- LAVIPHARM S.A. announces the appointment of Ms. Katerina Karapa as Chief Quality Officer (CQO).
Ms. Karapa holds degrees in Chemistry and Analytical Chemistry (Roger Williams University & Northeastern University, USA) and an Executive MBA from ALBA Graduate Business School - ACG. She brings over 29 years of experience in the pharmaceutical industry, including 24 years with the FAMAR Group in senior roles spanning Quality Assurance, Quality Management, and Regulatory Governance. She is a Board Member of the ISPE GR & CY Affiliate.
This appointment reaffirms Lavipharm's ongoing commitment to quality and regulatory compliance, in alignment with the requirements of international regulatory authorities.
This announcement is issued in accordance with the provisions of the Athens Stock Exchange Rulebook, Law 3556/2007, and Regulation (EU) 596/2014 (MAR).
For further information:
Corporate Communications
Vivienne Thomas
Tel: +30 2106691404
[email protected]